世界の子宮ポリープ治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Uterine Polyps Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5007 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、子宮ポリープ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、その他）、用途別市場規模（病院、外科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・子宮ポリープ治療薬の市場動向 ・企業の競争状況、市場シェア ・子宮ポリープ治療薬の種類別市場規模と予測2016-2027（経口、注射、その他） ・子宮ポリープ治療薬の用途別市場規模と予測2016-2027（病院、外科医院、その他） ・子宮ポリープ治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・子宮ポリープ治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮ポリープ治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮ポリープ治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮ポリープ治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GSK、Roche、Pfizer、Novartis、Merck、Bristol-Myers、Sanofi、Teva Pharmaceutical Industries、Amgen、Mylan、Sun Pharmaceutical Industries） ・結論

Uterine polyps are common gynecological diseases. Broadly speaking, it refers to all tumors attached to the uterine wall by slender pedicle. Mostly benign.

Market Analysis and Insights: Global Uterine Polyps Drug Market
The global Uterine Polyps Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Uterine Polyps Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Uterine Polyps Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Uterine Polyps Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Uterine Polyps Drug market.

Global Uterine Polyps Drug Scope and Market Size
Uterine Polyps Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Polyps Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Injection
Other

Segment by Application
Hospital
Clinic
Homecare
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
Roche
Pfizer
Novartis
Merck
Bristol-Myers
Sanofi
Teva Pharmaceutical Industries
Amgen
Mylan
Sun Pharmaceutical Industries

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uterine Polyps Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Uterine Polyps Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Homecare
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Uterine Polyps Drug Market Perspective (2016-2027)
2.2 Uterine Polyps Drug Growth Trends by Regions
2.2.1 Uterine Polyps Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Uterine Polyps Drug Historic Market Share by Regions (2016-2021)
2.2.3 Uterine Polyps Drug Forecasted Market Size by Regions (2022-2027)
2.3 Uterine Polyps Drug Industry Dynamic
2.3.1 Uterine Polyps Drug Market Trends
2.3.2 Uterine Polyps Drug Market Drivers
2.3.3 Uterine Polyps Drug Market Challenges
2.3.4 Uterine Polyps Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Uterine Polyps Drug Players by Revenue
3.1.1 Global Top Uterine Polyps Drug Players by Revenue (2016-2021)
3.1.2 Global Uterine Polyps Drug Revenue Market Share by Players (2016-2021)
3.2 Global Uterine Polyps Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Uterine Polyps Drug Revenue
3.4 Global Uterine Polyps Drug Market Concentration Ratio
3.4.1 Global Uterine Polyps Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uterine Polyps Drug Revenue in 2020
3.5 Uterine Polyps Drug Key Players Head office and Area Served
3.6 Key Players Uterine Polyps Drug Product Solution and Service
3.7 Date of Enter into Uterine Polyps Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Uterine Polyps Drug Breakdown Data by Type
4.1 Global Uterine Polyps Drug Historic Market Size by Type (2016-2021)
4.2 Global Uterine Polyps Drug Forecasted Market Size by Type (2022-2027)

5 Uterine Polyps Drug Breakdown Data by Application
5.1 Global Uterine Polyps Drug Historic Market Size by Application (2016-2021)
5.2 Global Uterine Polyps Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Uterine Polyps Drug Market Size (2016-2027)
6.2 North America Uterine Polyps Drug Market Size by Type
6.2.1 North America Uterine Polyps Drug Market Size by Type (2016-2021)
6.2.2 North America Uterine Polyps Drug Market Size by Type (2022-2027)
6.2.3 North America Uterine Polyps Drug Market Size by Type (2016-2027)
6.3 North America Uterine Polyps Drug Market Size by Application
6.3.1 North America Uterine Polyps Drug Market Size by Application (2016-2021)
6.3.2 North America Uterine Polyps Drug Market Size by Application (2022-2027)
6.3.3 North America Uterine Polyps Drug Market Size by Application (2016-2027)
6.4 North America Uterine Polyps Drug Market Size by Country
6.4.1 North America Uterine Polyps Drug Market Size by Country (2016-2021)
6.4.2 North America Uterine Polyps Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Uterine Polyps Drug Market Size (2016-2027)
7.2 Europe Uterine Polyps Drug Market Size by Type
7.2.1 Europe Uterine Polyps Drug Market Size by Type (2016-2021)
7.2.2 Europe Uterine Polyps Drug Market Size by Type (2022-2027)
7.2.3 Europe Uterine Polyps Drug Market Size by Type (2016-2027)
7.3 Europe Uterine Polyps Drug Market Size by Application
7.3.1 Europe Uterine Polyps Drug Market Size by Application (2016-2021)
7.3.2 Europe Uterine Polyps Drug Market Size by Application (2022-2027)
7.3.3 Europe Uterine Polyps Drug Market Size by Application (2016-2027)
7.4 Europe Uterine Polyps Drug Market Size by Country
7.4.1 Europe Uterine Polyps Drug Market Size by Country (2016-2021)
7.4.2 Europe Uterine Polyps Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Uterine Polyps Drug Market Size (2016-2027)
8.2 Asia-Pacific Uterine Polyps Drug Market Size by Type
8.2.1 Asia-Pacific Uterine Polyps Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Uterine Polyps Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Uterine Polyps Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Uterine Polyps Drug Market Size by Application
8.3.1 Asia-Pacific Uterine Polyps Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Uterine Polyps Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Uterine Polyps Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Uterine Polyps Drug Market Size by Region
8.4.1 Asia-Pacific Uterine Polyps Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Uterine Polyps Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Uterine Polyps Drug Market Size (2016-2027)
9.2 Latin America Uterine Polyps Drug Market Size by Type
9.2.1 Latin America Uterine Polyps Drug Market Size by Type (2016-2021)
9.2.2 Latin America Uterine Polyps Drug Market Size by Type (2022-2027)
9.2.3 Latin America Uterine Polyps Drug Market Size by Type (2016-2027)
9.3 Latin America Uterine Polyps Drug Market Size by Application
9.3.1 Latin America Uterine Polyps Drug Market Size by Application (2016-2021)
9.3.2 Latin America Uterine Polyps Drug Market Size by Application (2022-2027)
9.3.3 Latin America Uterine Polyps Drug Market Size by Application (2016-2027)
9.4 Latin America Uterine Polyps Drug Market Size by Country
9.4.1 Latin America Uterine Polyps Drug Market Size by Country (2016-2021)
9.4.2 Latin America Uterine Polyps Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Uterine Polyps Drug Market Size (2016-2027)
10.2 Middle East & Africa Uterine Polyps Drug Market Size by Type
10.2.1 Middle East & Africa Uterine Polyps Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Uterine Polyps Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Uterine Polyps Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Uterine Polyps Drug Market Size by Application
10.3.1 Middle East & Africa Uterine Polyps Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Uterine Polyps Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Uterine Polyps Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Uterine Polyps Drug Market Size by Country
10.4.1 Middle East & Africa Uterine Polyps Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Uterine Polyps Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Uterine Polyps Drug Introduction
11.1.4 GSK Revenue in Uterine Polyps Drug Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Uterine Polyps Drug Introduction
11.2.4 Roche Revenue in Uterine Polyps Drug Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Uterine Polyps Drug Introduction
11.3.4 Pfizer Revenue in Uterine Polyps Drug Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Uterine Polyps Drug Introduction
11.4.4 Novartis Revenue in Uterine Polyps Drug Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Uterine Polyps Drug Introduction
11.5.4 Merck Revenue in Uterine Polyps Drug Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Bristol-Myers
11.6.1 Bristol-Myers Company Details
11.6.2 Bristol-Myers Business Overview
11.6.3 Bristol-Myers Uterine Polyps Drug Introduction
11.6.4 Bristol-Myers Revenue in Uterine Polyps Drug Business (2016-2021)
11.6.5 Bristol-Myers Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Uterine Polyps Drug Introduction
11.7.4 Sanofi Revenue in Uterine Polyps Drug Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Uterine Polyps Drug Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Uterine Polyps Drug Business (2016-2021)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Uterine Polyps Drug Introduction
11.9.4 Amgen Revenue in Uterine Polyps Drug Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Uterine Polyps Drug Introduction
11.10.4 Mylan Revenue in Uterine Polyps Drug Business (2016-2021)
11.10.5 Mylan Recent Development
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Company Details
11.11.2 Sun Pharmaceutical Industries Business Overview
11.11.3 Sun Pharmaceutical Industries Uterine Polyps Drug Introduction
11.11.4 Sun Pharmaceutical Industries Revenue in Uterine Polyps Drug Business (2016-2021)
11.11.5 Sun Pharmaceutical Industries Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Uterine Polyps Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Other
Table 5. Global Uterine Polyps Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Uterine Polyps Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Uterine Polyps Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Uterine Polyps Drug Market Share by Regions (2016-2021)
Table 9. Global Uterine Polyps Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Uterine Polyps Drug Market Share by Regions (2022-2027)
Table 11. Uterine Polyps Drug Market Trends
Table 12. Uterine Polyps Drug Market Drivers
Table 13. Uterine Polyps Drug Market Challenges
Table 14. Uterine Polyps Drug Market Restraints
Table 15. Global Uterine Polyps Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Uterine Polyps Drug Market Share by Players (2016-2021)
Table 17. Global Top Uterine Polyps Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Polyps Drug as of 2020)
Table 18. Ranking of Global Top Uterine Polyps Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Uterine Polyps Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Uterine Polyps Drug Product Solution and Service
Table 22. Date of Enter into Uterine Polyps Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Uterine Polyps Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Uterine Polyps Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Uterine Polyps Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Uterine Polyps Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Uterine Polyps Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Uterine Polyps Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Uterine Polyps Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Uterine Polyps Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Uterine Polyps Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Uterine Polyps Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Uterine Polyps Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Uterine Polyps Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Uterine Polyps Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Uterine Polyps Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Uterine Polyps Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Uterine Polyps Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Uterine Polyps Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Uterine Polyps Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Uterine Polyps Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Uterine Polyps Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Uterine Polyps Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Uterine Polyps Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Uterine Polyps Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Uterine Polyps Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Uterine Polyps Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Uterine Polyps Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Uterine Polyps Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Uterine Polyps Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Uterine Polyps Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Uterine Polyps Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Uterine Polyps Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Uterine Polyps Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Uterine Polyps Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Uterine Polyps Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Uterine Polyps Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Uterine Polyps Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Uterine Polyps Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Uterine Polyps Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. GSK Company Details
Table 63. GSK Business Overview
Table 64. GSK Uterine Polyps Drug Product
Table 65. GSK Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 66. GSK Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Uterine Polyps Drug Product
Table 70. Roche Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Uterine Polyps Drug Product
Table 75. Pfizer Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Uterine Polyps Drug Product
Table 80. Novartis Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Uterine Polyps Drug Product
Table 85. Merck Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Bristol-Myers Company Details
Table 88. Bristol-Myers Business Overview
Table 89. Bristol-Myers Uterine Polyps Drug Product
Table 90. Bristol-Myers Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 91. Bristol-Myers Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Uterine Polyps Drug Product
Table 95. Sanofi Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Teva Pharmaceutical Industries Company Details
Table 98. Teva Pharmaceutical Industries Business Overview
Table 99. Teva Pharmaceutical Industries Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 100. Teva Pharmaceutical Industries Recent Development
Table 101. Amgen Company Details
Table 102. Amgen Business Overview
Table 103. Amgen Uterine Polyps Drug Product
Table 104. Amgen Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 105. Amgen Recent Development
Table 106. Mylan Company Details
Table 107. Mylan Business Overview
Table 108. Mylan Uterine Polyps Drug Product
Table 109. Mylan Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 110. Mylan Recent Development
Table 111. Sun Pharmaceutical Industries Company Details
Table 112. Sun Pharmaceutical Industries Business Overview
Table 113. Sun Pharmaceutical Industries Uterine Polyps Drug Product
Table 114. Sun Pharmaceutical Industries Revenue in Uterine Polyps Drug Business (2016-2021) & (US$ Million)
Table 115. Sun Pharmaceutical Industries Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uterine Polyps Drug Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Other Features
Figure 5. Global Uterine Polyps Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Homecare Case Studies
Figure 9. Other Case Studies
Figure 10. Uterine Polyps Drug Report Years Considered
Figure 11. Global Uterine Polyps Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Uterine Polyps Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Uterine Polyps Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Uterine Polyps Drug Market Share by Regions (2022-2027)
Figure 15. Global Uterine Polyps Drug Market Share by Players in 2020
Figure 16. Global Top Uterine Polyps Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Polyps Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Uterine Polyps Drug Revenue in 2020
Figure 18. Global Uterine Polyps Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Uterine Polyps Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Uterine Polyps Drug Market Share by Type (2016-2027)
Figure 22. North America Uterine Polyps Drug Market Share by Application (2016-2027)
Figure 23. North America Uterine Polyps Drug Market Share by Country (2016-2027)
Figure 24. United States Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Uterine Polyps Drug Market Share by Type (2016-2027)
Figure 28. Europe Uterine Polyps Drug Market Share by Application (2016-2027)
Figure 29. Europe Uterine Polyps Drug Market Share by Country (2016-2027)
Figure 30. Germany Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Uterine Polyps Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Uterine Polyps Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Uterine Polyps Drug Market Share by Region (2016-2027)
Figure 40. China Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Uterine Polyps Drug Market Share by Type (2016-2027)
Figure 48. Latin America Uterine Polyps Drug Market Share by Application (2016-2027)
Figure 49. Latin America Uterine Polyps Drug Market Share by Country (2016-2027)
Figure 50. Mexico Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Uterine Polyps Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Uterine Polyps Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Uterine Polyps Drug Market Share by Country (2016-2027)
Figure 56. Turkey Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Uterine Polyps Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GSK Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 64. Bristol-Myers Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 67. Amgen Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 69. Sun Pharmaceutical Industries Revenue Growth Rate in Uterine Polyps Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---